Table 3.
Summary of data collection via study questionnaires
| Preregistration | Day ≤1 (paper) |
Day 10 (app) |
Day 20 (app) |
Day 30 (app) |
Day 60 (app/paper) |
|
| Screening questionnaire | X | |||||
| Demographics | X | |||||
| Information about RA | X | |||||
| RAPID-3 | X | X | X | X | X | |
| Current medication(s) and non-pharmacological intervention use | X | X | ||||
| AIMS2-SF | X | X | X | X | X | |
| WHOQOL-BREF | X | X | X | X | X | |
| PSQI | X | X | ||||
| DBAS-16 | X | |||||
| SCI | X | |||||
| HADS | X | |||||
| ASES-8 | X | |||||
| CAQ-8 | X |
AIMS2-SF, Arthritis Impact Measurement Scale 2-Short Form; ASES-8, Arthritis Self-Efficacy Scale-8 item; CAQ-8, Committed Action Questionnaire; DBAS-16, Dysfunctional Beliefs and Attitudes about Sleep questionnaire; HADS, Hospital Anxiety and Depression Scale; PSQI, Pittsburgh Sleep Quality Index; RA, rheumatoid arthritis; RAPID-3, Routine Assessment of Patient Index Data 3; SCI, Sleep Condition Indicator.